EPSTI1 and breast carcinoma: As shown in the summary Tables 1 and 2, collectively, our findings reveal that PSMC3IP and EPSTI1 have a strong anti-apoptotic role in breast cancer cells, particularly in estrogen receptor positive and triple negative, by means of physical interaction with the apoptosis initiator caspase-8 (Fig. 8).